Navigation Links
Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimer's Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
Date:4/17/2012

Dr. LaFerla and his team, and are grateful for the University of California at Irvine's commitment of resources and expertise to help us test our First-in-Class vaccine, which we expect will result in a method to safely halt the progression and perhaps even prevent the onset of Alzheimer's disease."

RV03 is a product of Intellect's RECALL-VAX platform technology that is designed to produce antibodies that specifically target the unique molecular signatures ("neoepitopes") that exist only in products of protein metabolism. Relevant examples include the free amino terminus of amyloid (Amyloid beta) at the beta secretase site produced from the amyloid precursor protein and the free C terminus of delta tau from intact microtubule associated protein Tau produced by executioner caspases. In contrast to other Alzheimer's vaccines in development that target single proteins, RV03 is uniquely capable of eliciting an immune response against both Amyloid beta and delta tau at the same time.

"My laboratory was the first to demonstrate that Amyloid beta facilitates the accumulation of Tau through a variety of mechanisms including by interfering with proteasome function and by reducing a key chaperone protein called Chip," said Dr. LaFerla. "Therefore, we were excited to be asked to participate in the seminal work being done at Intellect Neurosciences to test the therapeutic and prophylactic potential of RV03.  Our combined research aims to develop the first dual vaccine against these two important therapeutic targets to prevent the irreversible damage and death of nerve cells caused by these two proteins."

Intellect Neurosciences' RECALL-VAX platform was recently featured in the industry publication, Fierce Vaccines (http://www.fiercevaccines.com/story/intellect-neurosciences-chases-holy-grail-alzheimers-preventive
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
2. Codexis Names Vice President, Intellectual Property
3. Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
4. CJPS Enterprises Provides New Strategies To Create Additional Revenues for Companies with Intellectual Property
5. Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
6. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
7. Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers
8. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
9. Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property
10. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
11. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that ... County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is ... from and how agriculture impacts their daily lives. This unique exhibit also features a ...
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry is ... with a focus on the Chinese situation. Major companies included in the propanol market ... Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides a ...
(Date:7/30/2015)...   Senomyx , Inc. (NASDAQ: SNMX ), ... discover, develop, and commercialize novel flavor ingredients for the ... results for the second quarter 2015. ... on track to achieve our commercial and financial goals," ... the Company. "Since our last quarterly earnings report, our ...
(Date:7/30/2015)... WARRINGTON, Pa. , July 30, 2015 /PRNewswire/ ... announced that it has received the second $1.0M ... Business Innovation Research (SBIR) grant valued at up ... the company,s aerosolized KL4 surfactant as a potential ... lung injury.  Discovery Labs was awarded an initial ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... 28 Volcano Corporation,(Nasdaq: VOLC ), a leader ... diagnosis and treatment of coronary and peripheral artery,disease, today ... the,third quarter and first nine months of fiscal 2008 ... conference call to discuss its financial,results and operating activities ...
... Ontario biotech companies work together on innovative bone ... - Thomas Wellner, President and CEO of,Therapure BioPharma ... of,Induce Biologics Inc. today announced a development partnership ... of selected growth,factors for stimulating bone regeneration. Such ...
... Inc., (http://www.sirnaomics.com ) announced today that the ... research) grant from National Cancer Institute,(NCI), National ... company founded in early 2007, is dedicated ... targeted therapeutic,development. The company,s multi-targeted siRNA therapeutic ...
Cached Biology Technology:Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc. 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 3
(Date:7/30/2015)... 30, 2015 Cellecta, Inc., a U.S.-based ... analysis and biomarker discovery, announced the release of ... targeting all human protein coding genes. CRISPR technology ... a gene,s function. Cellecta,s new Human Whole Genome ... tool so that researchers can investigate in a ...
(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. ... a biometric authentication company focused on the growing ... smart wallet, announces that it has filed provisional ... and Method. This invention highlights ... only authorizes an account, but also the user ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4
... the most fundamental processes in the life of plants because ... University of Leeds researchers. Arabidopsis thaliana also known ... pavements all over Europe and Asia, but the small white ... the plant world. It has become the dominant "model ...
... depends on what you are, according to a study published ... "Ecologists have long viewed the darkness of a moonless ... Laura Prugh, a wildlife biologist at the University of Alaska ... go about their business in relative safety from lurking predators. ...
... SAN FRANCISCO, CAOctober 21, 2013Two pioneering online biology video ... iBiology.org , a new website with even more to ... predecessors, iBiology.org will continue to provide videos by world-class ... aims to appeal to a broad audience, says iBiology ...
Cached Biology News:Model plant misled scientists about multicellular growth 2Model plant misled scientists about multicellular growth 3Study: Death by moonlight? Not always 22 online science video pioneers combine to form new iBiology.org 2
... Mouse/Rat Tissue Extract Protein Array Kit is ... tissue extracts. The expression of a protein ... protein specific antibody. When the antibody binds ... a sensitive chemiluminescent or fluorescent signal created ...
... StabilGuard Choice Microsphere/Microarray Stabilizer is a is ... Stabilizer. This product is an aqueous ... PBS buffer (phosphate buffered saline), pH 6.6 ... combination of 0.02% methylisothiazolone and 0.02% bromonitrodioxane ...
... is an aqueous-based mounting medium designed ... sections. Gel/Mount is especially recommended when ... or FluoroBlue. It can also be ... as fluorescein (FITC), Rhodamine (TMRITC) and ...
...
Biology Products: